Carmat: Airbus lowers its stake, debt is reduced

(CercleFinance.com) - Carmat announced on Monday that it had purchased two million shares from Airbus, one of its founding shareholders, for a symbolic one euro, to be used to repay its debt.


Through an off-market block sale via its subsidiary Matra Défense, the aircraft manufacturer sold full ownership of these shares, worth almost two million euros.

The net proceeds of the transaction are to be paid to the European Investment Bank (EIB) to repay its loan.

A founder of Carmat in 2008, alongside Professor Alain Carpentier, Airbus has since supported the company, particularly at the technical level, throughout its research and development (R&D) process, and then the industrialization of the Aeson artificial heart.

As Carmat is now well on the way to commercializing Aeson, and Airbus has no expertise in the field of medical devices, the two companies say they have agreed to reduce Airbus' stake in Carmat, in which Airbus still held a stake of around 6.1%.

On the Paris Bourse, Carmat shares were up 2.8% in early trading on Monday morning. Airbus shares were down by around 0.5%.

Copyright (c) 2024 CercleFinance.com. All rights reserved.